Skip to content

BioMed Research International

4 papers in the library · 257 citations · publishing 2014-2015

Papers

25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug

BioMed Research International January 1, 2014 Francesco Saverio Bersani, Ornella Corazza, Gabriella Albano et al. 98 citations

25C-NBOMe, sold online as legal LSD or under names like 'N-bomb' and 'Pandora', is a partial agonist of 5-HT2A receptors that carries a high risk of overdose, with acute toxicity and fatalities reported. It is taken orally, sublingually, nasally, by injection, vaginally, rectally, or smoked, producing effects such as sublingual numbing, stimulation, hallucinations, dissociation, and anxiety. Its use is an emerging phenomenon increased by low-cost online availability, and health professionals should be informed about this trend.

Pharmacology of Hallucinations: Several Mechanisms for One Single Symptom?

BioMed Research International January 1, 2014 Benjamin Rolland, Renaud Jardri, Ali Amad et al. 96 citations

Hallucinations arise from at least three distinct pharmacological pathways: activation of dopamine D2 receptors by psychostimulants, activation of serotonin 5HT2A receptors by psychedelics, and blockage of glutamate NMDA receptors by dissociative anesthetics. In schizophrenia, the relative roles of NMDA and dopamine receptors remain debated, and slight clinical differences appear depending on the cause. This narrative review synthesizes how leading researchers have approached whether the concept of hallucination is clinically and neurobiologically homogeneous. Some favor a single mechanism, while others propose integrated theories based on pharmacological psychosis models. The authors suggest that although common neurobiological pathways may exist, each system likely has unique properties that explain observed clinical differences.

Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions

BioMed Research International January 1, 2015 Débora González, Marta Torrens, Magı́ Farré 44 citations

A single 20 mg dose of 2C-B in healthy recreational users produced positive subjective effects, including euphoria and well-being, along with reduced anger. However, it increased reactivity to negative emotional stimuli and impaired recognition of happy facial expressions. Speech became more emotional, noticeable to others. Mild increases in blood pressure and heart rate occurred. The authors conclude that 2C-B's emotional profile fits an entactogen with psychedelic properties.

Effects of Stress and MDMA on Hippocampal Gene Expression

BioMed Research International January 1, 2014 Georg F. Weber, Bethann N. Johnson, Bryan K. Yamamoto et al. 19 citations

MDMA, a substituted amphetamine and recreational drug, can produce mood-enhancing short-term effects that may lead to its use under stress. Clinical studies suggest MDMA treatment might alleviate symptoms of stress disorders like PTSD, but repeated use causes lasting deficits in serotonergic nerve terminal markers, indicating possible neurotoxicity. Chronic stress worsens MDMA-induced serotonergic neurotoxicity. In rats, MDMA altered gene expression in the hippocampus related to protein folding and neuropeptide signaling. In stressed rats, MDMA changed genetic responses affecting sensory processing and tissue damage responses, and reversed stress-induced downregulation of circadian rhythm genes. These transcriptional changes accompany the drug's persistent effects on neuronal structure and function.